Literature DB >> 11275262

Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas.

L Diaw1, D Siwarski, W DuBois, G Jones, K Huppi.   

Abstract

Rearrangement of the light chain locus is believed to be an ordered process in which Iglambda rearrangements only occur if Igkappa rearrangements are found to be non-productive or self-reactive. Secondary rearrangements of the B-cell receptor (BCR) have shown, however, that rescue of abortive Igkappa rearrangements or autoreactive B cells can be achieved through receptor editing using upstream V-regions as the template sequences. Since secondary rearrangement can occur in the periphery, possibly in a subset of B cells maintaining constitutive Rag activity, it is conceivable that two light chains (kappa:kappa or kappa:lambda) could be expressed in these cells, apparently in violation of allelic exclusion. Previously, we have reported that silicone-induced plasmacytomas (SIPCs) exhibit dual expression and ongoing rearrangements of Igkappa and Iglambda. In this paper, we show by ELISA that both Igkappa and Iglambda are found at the protein level, but are secreted in different amounts. Furthermore, we demonstrate by micro-manipulation and RT-PCR amplification that Igkappa and Iglambda are simultaneously expressed in a single SIPC cell. We propose that these dual-expressing cells, found intermittently in cases of plasmacytomas (PCs), may have originally been immature B cells when transformed but now are maintained as a long-lived mature B cell found infrequently in the tumor population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11275262     DOI: 10.1016/s0161-5890(00)00100-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

Review 1.  Double light chain producing lymphocytes: an enigma of allelic exclusion.

Authors:  L Diaw; D Siwarski; K Huppi
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.

Authors:  Chrysoula Belessi; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Katerina Hatzi; Tatjana Smilevska; Niki Stavroyianni; Fotini Marantidou; George Paterakis; Athanasios Fassas; Achilles Anagnostopoulos; Nikolaos Laoutaris
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

3.  Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity.

Authors:  C Sirac; C Carrion; S Duchez; I Comte; M Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.

Authors:  Ang Cui; Roberto Di Niro; Jason A Vander Heiden; Adrian W Briggs; Kris Adams; Tamara Gilbert; Kevin C O'Connor; Francois Vigneault; Mark J Shlomchik; Steven H Kleinstein
Journal:  J Immunol       Date:  2016-10-05       Impact factor: 5.422

5.  Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.

Authors:  Shahanawaz Jiwani; Joshua Bornhost; Daisy Alapat
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production.

Authors:  José Luis Vela; Djemel Aït-Azzouzene; Bao Hoa Duong; Takayuki Ota; David Nemazee
Journal:  Immunity       Date:  2008-02-07       Impact factor: 31.745

7.  Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.

Authors:  Linda M Slot; Rochelle D Vergroesen; Priscilla F Kerkman; Ellen Staudinger; Sanne Reijm; Hugo J van Dooren; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes; Hans U Scherer
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

8.  A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains.

Authors:  Ryota Matsuoka; Noriaki Sakamoto; Takayasu Kato; Shigeru Chiba; Masayuki Noguchi
Journal:  Eur J Med Res       Date:  2021-12-20       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.